Symbol="CDTX"
AssetType="Common Stock"
Name="Cidara Therapeutics Inc"
Description="Cidara Therapeutics, Inc., a biotechnology company, is focused on the discovery, development, and commercialization of new long-acting anti-infectives for the treatment and prevention of disease in the United States. The company is headquartered in San Diego, California."
CIK="1610618"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="6310 NANCY RIDGE DRIVE, SUITE 101, SAN DIEGO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="88000000"
EBITDA="-8344000"
PERatio="None"
PEGRatio="0"
BookValue="0.298"
DividendPerShare="0"
DividendYield="0"
EPS="-0.12"
RevenuePerShareTTM="1.147"
ProfitMargin="-0.0999"
OperatingMarginTTM="-0.102"
ReturnOnAssetsTTM="-0.0774"
ReturnOnEquityTTM="-0.523"
RevenueTTM="83169000"
GrossProfitTTM="-11232000"
DilutedEPSTTM="-0.12"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="2.656"
AnalystTargetPrice="6"
TrailingPE="-"
ForwardPE="1.785"
PriceToSalesRatioTTM="0.569"
PriceToBookRatio="3.949"
EVToRevenue="0.276"
EVToEBITDA="0.471"
Beta="1.258"
num_52WeekHigh="2.1"
num_52WeekLow="0.46"
num_50DayMovingAverage="1.201"
num_200DayMovingAverage="1.062"
SharesOutstanding="90025000"
DividendDate="None"
ExDividendDate="None"
symbol="CDTX"
open="1.05"
high="1.08"
low="0.90"
price="1.06"
volume="2541483.00"
latest_trading_day="2023-07-21"
previous_close="1.10"
change="-0.04"
change_percent="-3.6364%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="42"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="TRUE"
Aroon_momentum="58"
Volume_recent_avg="2202424"
Change_recent_avg="0.01"
Delta_recent_avg="0.11"
Variance_recent_avg="0.06"
Change_ratio_recent_avg="-0.44"
RSI_change="FALSE"
ADX_change="FALSE"
Aroon_signal="negative"
Aroon_change="TRUE"
Aroon_momentum_positive="58"
Aroon_momentum_negative="42"
image_negative_thumbnail_id_1="167"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0009.jpeg"
image_negative_thumbnail_id_2="173"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0003.jpeg"
image_neutral_thumbnail_id_1="535"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0064.jpeg"
image_neutral_thumbnail_id_2="582"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0017.jpeg"
image_positive_thumbnail_id_1="995"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0157.jpeg"
image_positive_thumbnail_id_2="655"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0053.jpeg"
image_professor_thumbnail_id_1="1168"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0002.jpeg"
image_professor_thumbnail_id_2="1188"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0022.jpeg"
